H. R. 938, BLOCKING Act of 2019.

Summary: Amends the Federal Food, Drug, and Cosmetic Act, with respect to eligibility for approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval, and for other purposes. Cosponsors

ANGIE CRAIG’S POSITION:  Representative Craig cosponsored the bill on 3/25/19.

STATUS: Introduced 1/31/19 by Rep. Schrader, Kurt [D-OR-5]. 

ORGANIZATIONS IN SUPPORT OF THE BILL:

  • Check back as organizations publicly support the bill.

ADDITIONAL DETAIL:

  • Link to the text of the bill.
  • Link to bill information (support and opposition) on Countable.

Leave a Reply

Your email address will not be published. Required fields are marked *